Similarly, APOE levels were also found to be higher in severe group (group 1; ≥ 5 anti-VEGF/year and continuing for > 36 months) as compared to mild group of AMD, though it was not statistically significant. This evidence concerns the gene VEGFA and age-related macular degeneration.